Overview
The IASLC Education Committee presents a one-hour live session focused on the review and discussion of the most impactful and important topics presented at the 2025 IASLC Asia Conference on Lung Cancer (ACLC) meeting.
- Describe key updates from ACLC25, including emerging clinical trends and research highlights relevant to lung cancer diagnosis and treatment.
- Summarize current approaches to the molecular diagnosis and management of leptomeningeal metastases (LM) in advanced lung cancer.
- Identify practical considerations for translating new evidence and evolving paradigms into clinical practice.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.
The International Association for the Study of Lung Cancer designates the live format for this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- Describe key updates from ACLC25, including emerging clinical trends and research highlights relevant to lung cancer diagnosis and treatment.
- Summarize current approaches to the molecular diagnosis and management of leptomeningeal metastases (LM) in advanced lung cancer.
- Identify practical considerations for translating new evidence and evolving paradigms into clinical practice.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.
The International Association for the Study of Lung Cancer designates the live format for this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Share
Participants
Hidehito Horinouchi
MD, PhD
Assistant Chief of the Department of Thoracic Oncology
National Cancer Center Hospital
Wendy Cooper
MBBS, PhD
Senior Staff Specialist in Tissue Pathology and Diagnostic Oncology
Royal Prince Alfred Hospital
Sushma Agrawal
MD
Professor
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Meimei Zheng
MD
Medical Oncologist
Guangdong Provincial People's Hospital